Htg Molecular Diagnostics, Inc.

HTG Molecular Diagnostics is a provider of instruments and reagents for molecular profiling applications. The company's products empower molecular testing in oncology, translational research, and precision medicine. HTG's technology enables highly multiplexed gene expression profiling using only a small amount of input material. The company's mission is to contribute to improving patient outcomes through accurate and timely molecular testing.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

8 Patents

#79 in Tucson, AZ

#467 in Arizona

#35,954 in US

Tucson, AZ, United States of America

Htg Molecular Diagnostics, Inc.

Forward Citations = 131

20 inventors:

Bruce Seligmann (6 out of 19 patents)

Matt Rounseville (4 out of 4 patents)

John W Luecke (3 out of 3 patents)

4. Ihab Botros (3 out of 3 patents)

5. Bj Kerns (2 out of 2 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Htg Molecular Diagnostics, Inc.. Retrieved from https://idiyas.com/company/htg-molecular-diagnostics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (CIPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

8 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]